Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis
Samer Gawrieh(Indiana University School of Medicine), Ashutosh Barve, Srinivasan Dasarathy(Cleveland Clinic), Mack C. Mitchell(Southwestern Medical Center), Svetlana Radaeva(National Institute on Alcohol Abuse and Alcoholism), Matt Cave, Craig J. McClain(University of Louisville), Patrick S. Kamath(Mayo Clinic in Arizona), Loretta Jophlin(University of Louisville), Lauren Nephew(Indiana University Health), Velimir A. Luketic(University of Padua), Laura E. Nagy(Cleveland Clinic), Thomas G. Cotter(University College Cork), Ramón Bataller(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Hugo E. Vargas(Mayo Clinic in Arizona), Raj Vuppalanchi(University of Pennsylvania), Vatsalya Vatsalya, Suman Kumar Jha, Qing Tang(Sichuan University), Vijay H. Shah(Mayo Clinic in Arizona), David Streem, Wanzhu Tu(Indiana University Health), Douglas A. Simonetto(Mayo Clinic), Amy Attaway(Cleveland Clinic), Luis Marsano, Thomas A. Kerr, Kavish R. Patidar(Michael E. DeBakey VA Medical Center), Nicole Welch(Cleveland Clinic), Arun J. Sanyal(Virginia Commonwealth University), Naga Chalasani(Indiana University – Purdue University Indianapolis), Annette Bellar, Bruce Barton(University of Massachusetts Chan Medical School), Stephanie Taylor, Ashley Growley, L Yoder, H. Franklin Herlong, Sara O'Connor(Cleveland Clinic), Jaividhya Dasarathy(Cleveland Clinic), Niha Samala, Arun J. Sanyal(Association Clinique et Thérapeutique Infantile du Val de Marne), Amon Asgharpour, Liu Yang, Gyöngyi Szabó(Beth Israel Deaconess Medical Center)
Cited by 54
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Liver fibrosis
|Journal of Clinical Investigation|2005|4.7k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k